Friday, August 14, 2026

Pyongyang Propaganda Links Kim’s Rule to Irreversible Nuclear Statehood

North Korea's Rodong Sinmun highlights Kim Jong Un's authority and nuclear status, praising his diplomatic efforts and military loyalty.

KAMCO Attains Top Safety Rating in Public Agency Evaluation

KAMCO (Korea Asset Management Corporation) announced on...

April 2026: Major Regulatory Actions on Herbal Patches and Antibiotics in South Korea

The FDA suspended manufacturing and sales of several products for regulatory violations, including herbal patches and antibiotic tablets.

Tag: Elevar Therapeutics

HLB’s Liraglutide: A Game-Changer in Cholangiocarcinoma Treatment with FDA Priority Review

HLB's Elevar Therapeutics receives FDA Priority Review for lirafugratinib, a promising treatment for cholangiocarcinoma with a 47% response rate.

Top News

- Our Sponsors Ad -

Follow us